Yendamuri et al evaluated prognostic factors associated with survival in patients with esophageal cancer. These can help to identify patients who may benefit from more aggressive management or use of a novel therapy. The authors are from the University of Texas M.D. Anderson Cancer Center in Houston.
Patient selection: either squamous cell carcinoma or adenocarcinoma without preoperative chemoradiation and without distant metastases (not M1).
Parameters:
(1) T status of the tumor
(2) N status of the tumor
(3) length of the tumor in cm
(4) status of final surgical margin
Parameter |
Finding |
Hazard Ratio |
T status |
T1 |
1 |
|
T2 |
1.9 |
|
T3 or T4 |
3.5 |
N status |
N0 |
1 |
|
N1 |
1.9 |
length of the tumor |
<= 3 cm |
1 |
|
> 3 cm |
2.1 |
status of final surgical margin |
negative for tumor |
1 |
|
positive for tumor |
2.7 |
cumulative hazard ratio =
= PRODUCT(all 4 parameters)
Interpretation:
• minimum cumulative hazard ratio: 1
• maximum cumulative hazard ratio: 37.7
• The higher the cumulative hazard ratio the greater the mortality rate.
• The length of the tumor affected survival. A small tumor (<= 1 cm) had a 5 year survival rate of 83% while a tumor > 3 cm had a survival less than 20%.
Specialty: Hematology Oncology, Surgery, general, Gastroenterology
ICD-10: ,